Morphic
Acquired- Employees
- 51–200
- Website
- morphictx.com
- Total Funding
- $131.5M
- Last Round
- $80.0M Series BSep 2018
- Rounds
- 2
About
Morphic is a Biotech company. It has raised $131.5M in total across 2 rounds, most recently a $80.0M Series B round in Sep 2018. Investors include Omega Funds, Eli Lilly and Novo Holdings A/S.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.